fatnews.com Fatnews Bitchute Channel Link Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Metformin causes small amount of weight loss in diabetics, but considerably reduces risk of death


    Posted by .(JavaScript must be enabled to view this email address)
    Tuesday, January 10, 2006 12:03 am Email this article
    Glucophage (metformin) causes a small amount of weight loss on the order of a couple of pounds when given to patients with diabetes. However, it appears to considerably reduce the risk of diabetes related diseases and death compare to other diabetes treatments according to a new review. RECOMMENDED FOR LIFE EXTENSION PATIENTS

    Dr. Ward Dean recommends to his life extension patients over 40

    Dr. Ward Dean, MD, who I have a great deal of respect for, recommends Glucophage (metformin) to all of his life extension patients over the age of 40.

    Dr. Ward Dean recommends 500 mg twice a day

    He recommends that patients take 500 mg twice a day.

    Take with food

    Comment: In my experience, it is best taken with food.

     

    MOST POTENT LIFE EXTENSION DRUG?

    Metformin’s stronger cousin most potent life extension drug available

    Dr. Dean has said that Vladamir Dilman, a famous Russian gerentologist, believed that phenformin, metformin’s stronger cousin which was removed from the market due to serious adverse effects in a small number of patients, was the most effective life-extending drug known.

     

    REDUCES DEATH AND DISEASE

    Metformin reduced risk of death and disease

    The current review paper found that Glucophage (metformin) considerably reduced the risk of disease and death in patients compared to other treatments.

    The amount of reduction seen in patients given Glucophage (metformin) compared to those given other forms of treatment including sulphonylureas or insulin is as follows:

    REFERENCE

    Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005, (3):CD002966.

    AUTHOR’S CONTACT INFORMATION

    Centro de Salud Pozuelo 1
    INSALUD - Madrid, Spain

    Emisora s/n
    Pozuelo de Alarcon
    Madrid, Spain, 28224

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.